Two Sigma Securities’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,330
Closed -$372K 2190
2025
Q4
$372K Buy
+6,330
New +$385K 0.05% 526
2025
Q2
Sell
-5,948
Closed -$349K 2073
2025
Q1
$349K Buy
+5,948
New +$403K 0.05% 513
2024
Q2
Sell
-3,004
Closed -$211K 3657
2024
Q1
$211K Buy
+3,004
New +$215K ﹤0.01% 2288
2023
Q1
Sell
-3,083
Closed -$256K 3253
2022
Q4
$256K Sell
3,083
-2,833
-48% -$225K 0.01% 1693
2022
Q3
$420K Buy
5,916
+2,472
+72% +$214K 0.01% 1248
2022
Q2
$298K Buy
+3,444
New +$323K 0.01% 1305
2021
Q4
Sell
-6,792
Closed -$823K 2031
2021
Q3
$823K Buy
6,792
+3,768
+125% +$459K 0.02% 578
2021
Q2
$340K Buy
3,024
+40
+1% +$4.21K 0.01% 900
2021
Q1
$285K Buy
+2,984
New +$272K 0.02% 459
2018
Q2
Sell
-10,776
Closed -$407K 3003
2018
Q1
$407K Buy
+10,776
New +$381K ﹤0.01% 1803

Other funds holding TECH

Two Sigma Securities's TECH Position: Q1 2026 in Review

Two Sigma Securities sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 6,330 shares — an estimated $372K sold.

Two Sigma Securities first reported a position in TECH in Q1 2018 and held it in 10 quarters. The position peaked at $823K in Q3 2021. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Two Sigma Securities reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 6,330 Bio-Techne shares in Q1 2026, an estimated $372K.
  • Two Sigma Securities first reported a position in Bio-Techne in Q1 2018 and held it in 10 quarters.
  • Two Sigma Securities's Bio-Techne position peaked at $823K in Q3 2021.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.